Market Overview

Jefferies Raises Pfizer PT, Says Company Has Multiple Ways To Win

Share:

Jefferies on Monday issued a report on Pfizer Inc. (NYSE: PFE), raising its price target from $42 to $45. Jefferies rates Pfizer as a Buy.

Analysts Jeffrey Holland, David Gu, Ian Hilliker and Sissi Qiong Hai wrote, "We expect Pfizer shares to significantly appreciate over the next 1-2 years based on a better than expected launch of Ibrance, greater appreciation of the durable growth on offer in GEP, further accretive and potentially tax-driven M&A, and the separation of GEP by 2017 at a minimum from the rest of the business."

Early surveys show that Ibrance will beat consensus revenue estimates as it is expected to be one of the fastest oncology product launches ever. Jefferies said that peak sales could exceed over $13 billion. There is further upside for Pfizer based on the separation of its Global Established Product business line, which should crystallize current hidden value along with the use of cash for M&A and tax-driven deals for both the innovative and value sides of the business.

Pfizer closed Friday at $34.25.

Latest Ratings for PFE

DateFirmActionFromTo
Oct 2019ReinstatesNeutral
Aug 2019UpgradesSellHold
Aug 2019MaintainsEqual-Weight

View More Analyst Ratings for PFE
View the Latest Analyst Ratings

Posted-In: David Gu Ian Hilliker Jefferies Jeffery Holford Sissi Qiong HaiAnalyst Color Price Target Analyst Ratings

 

Related Articles (PFE)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
VIACJP MorganReinstates50.0
NUVASVB LeerinkMaintains92.0
SRPTCantor FitzgeraldMaintains211.0
SRPTPiperJaffrayMaintains210.0
LULUGoldman SachsMaintains219.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

EUR/USD Moves Higher

Don't Forget About mREITs...Here's A Top Pick From Some Very Smart Analysts